ID ESYT1_RAT Reviewed; 1088 AA. AC Q9Z1X1; Q3T1L3; DT 16-MAY-2006, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-1999, sequence version 1. DT 24-JAN-2024, entry version 136. DE RecName: Full=Extended synaptotagmin-1; DE Short=E-Syt1; DE AltName: Full=Membrane-bound C2 domain-containing protein; DE AltName: Full=vp115; GN Name=Esyt1; Synonyms=Fam62a, Mbc2; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY. RC STRAIN=Sprague-Dawley; RX PubMed=10350628; DOI=10.1016/s0167-4838(99)00068-0; RA Morris N.J., Ross S.A., Neveu J.M., Lane W.S., Lienhard G.E.; RT "Cloning and preliminary characterization of a 121 kDa protein with RT multiple predicted C2 domains."; RL Biochim. Biophys. Acta 1431:525-530(1999). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Prostate; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [3] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-993, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=22673903; DOI=10.1038/ncomms1871; RA Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C., RA Olsen J.V.; RT "Quantitative maps of protein phosphorylation sites across 14 different rat RT organs and tissues."; RL Nat. Commun. 3:876-876(2012). CC -!- FUNCTION: Binds glycerophospholipids in a barrel-like domain and may CC play a role in cellular lipid transport (By similarity). Binds calcium CC (via the C2 domains) and translocates to sites of contact between the CC endoplasmic reticulum and the cell membrane in response to increased CC cytosolic calcium levels. Helps tether the endoplasmic reticulum to the CC cell membrane and promotes the formation of appositions between the CC endoplasmic reticulum and the cell membrane (By similarity). CC {ECO:0000250}. CC -!- SUBUNIT: Interacts with ESYT2 and ESYT3. Interacts (phosphorylated CC form) with SLC2A4 (By similarity). {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane CC {ECO:0000250|UniProtKB:Q9BSJ8}; Multi-pass membrane protein CC {ECO:0000255}. Cell membrane {ECO:0000250|UniProtKB:Q9BSJ8}; Peripheral CC membrane protein {ECO:0000250|UniProtKB:Q9BSJ8}. Note=Localizes CC primarily to the endoplasmic reticulum. Recruited to sites of contact CC between the endoplasmic reticulum and the cell membrane in response to CC increased cytosolic calcium levels. {ECO:0000250|UniProtKB:Q9BSJ8}. CC -!- TISSUE SPECIFICITY: Ubiquitously expressed with a higher expression in CC spleen and white adipose tissue. {ECO:0000269|PubMed:10350628}. CC -!- DOMAIN: Anchored to the endoplasmic reticulum membrane by a CC transmembrane hairpin structure; both N-terminus and C-terminus are CC cytoplasmic. {ECO:0000250}. CC -!- DOMAIN: The C2 domains mediate lipid and calcium binding. The N- CC terminal C2 domain binds calcium ions and is important for calcium- CC dependent lipid binding and interaction with membranes. Two calcium CC ions are bound at a high-affinity site and a third calcium ion is bound CC with lower affinity. May bind up to four calcium ions. In contrast, the CC second C2 domain apparently does not bind calcium. The third C2 domain CC mediates interaction with membranes enriched in phosphatidylinositol CC 4,5-bisphosphate and is required for translocation to the cell membrane CC in response to increased cytosolic calcium levels (By similarity). CC {ECO:0000250}. CC -!- DOMAIN: The SMP-LTD domain is a barrel-like domain that binds CC glycerophospholipids in its interior (By similarity). CC {ECO:0000250|UniProtKB:A0FGR8}. CC -!- PTM: Phosphorylated on Ser residues in insulin-treated adipocytes (in CC vitro); this promotes interaction with SLC2A4. {ECO:0000250}. CC -!- SIMILARITY: Belongs to the extended synaptotagmin family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF099138; AAD10051.1; -; mRNA. DR EMBL; BC101857; AAI01858.1; -; mRNA. DR RefSeq; NP_058945.2; NM_017249.2. DR AlphaFoldDB; Q9Z1X1; -. DR SMR; Q9Z1X1; -. DR BioGRID; 248212; 2. DR IntAct; Q9Z1X1; 1. DR STRING; 10116.ENSRNOP00000070299; -. DR iPTMnet; Q9Z1X1; -. DR PhosphoSitePlus; Q9Z1X1; -. DR jPOST; Q9Z1X1; -. DR PaxDb; 10116-ENSRNOP00000006119; -. DR GeneID; 29579; -. DR KEGG; rno:29579; -. DR UCSC; RGD:3053; rat. DR AGR; RGD:3053; -. DR CTD; 23344; -. DR RGD; 3053; Esyt1. DR eggNOG; KOG1012; Eukaryota. DR InParanoid; Q9Z1X1; -. DR OrthoDB; 944695at2759; -. DR PhylomeDB; Q9Z1X1; -. DR TreeFam; TF324255; -. DR Reactome; R-RNO-9013149; RAC1 GTPase cycle. DR Reactome; R-RNO-9013404; RAC2 GTPase cycle. DR Reactome; R-RNO-9013405; RHOD GTPase cycle. DR Reactome; R-RNO-9013408; RHOG GTPase cycle. DR Reactome; R-RNO-9013423; RAC3 GTPase cycle. DR Reactome; R-RNO-9035034; RHOF GTPase cycle. DR Reactome; R-RNO-9840309; Glycosphingolipid biosynthesis. DR PRO; PR:Q9Z1X1; -. DR Proteomes; UP000002494; Unplaced. DR GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB. DR GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IBA:GO_Central. DR GO; GO:0005509; F:calcium ion binding; IBA:GO_Central. DR GO; GO:0005544; F:calcium-dependent phospholipid binding; IBA:GO_Central. DR GO; GO:0042802; F:identical protein binding; ISO:RGD. DR GO; GO:0031210; F:phosphatidylcholine binding; IBA:GO_Central. DR GO; GO:0008429; F:phosphatidylethanolamine binding; IBA:GO_Central. DR GO; GO:0035091; F:phosphatidylinositol binding; IBA:GO_Central. DR GO; GO:0120014; F:phospholipid transfer activity; ISS:UniProtKB. DR GO; GO:0061817; P:endoplasmic reticulum-plasma membrane tethering; IEA:InterPro. DR GO; GO:0120009; P:intermembrane lipid transfer; ISS:UniProtKB. DR CDD; cd08391; C2A_C2C_Synaptotagmin_like; 2. DR CDD; cd04050; C2B_Synaptotagmin-like; 2. DR CDD; cd04030; C2C_KIAA1228; 1. DR Gene3D; 2.60.40.150; C2 domain; 5. DR InterPro; IPR000008; C2_dom. DR InterPro; IPR035892; C2_domain_sf. DR InterPro; IPR037752; C2C_KIAA1228. DR InterPro; IPR037733; Ext_Synaptotagmin_C2A. DR InterPro; IPR037749; Ext_Synaptotagmin_C2B. DR InterPro; IPR031468; SMP_LBD. DR InterPro; IPR039010; Synaptotagmin_SMP. DR PANTHER; PTHR45761:SF3; EXTENDED SYNAPTOTAGMIN-1; 1. DR PANTHER; PTHR45761; EXTENDED SYNAPTOTAGMIN-LIKE PROTEIN 2, ISOFORM C; 1. DR Pfam; PF00168; C2; 5. DR Pfam; PF17047; SMP_LBD; 1. DR PRINTS; PR00360; C2DOMAIN. DR SMART; SM00239; C2; 5. DR SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 5. DR PROSITE; PS50004; C2; 5. DR PROSITE; PS51847; SMP; 1. PE 1: Evidence at protein level; KW Acetylation; Calcium; Cell membrane; Endoplasmic reticulum; KW Lipid transport; Lipid-binding; Membrane; Metal-binding; Phosphoprotein; KW Reference proteome; Repeat; Transmembrane; Transmembrane helix; Transport. FT CHAIN 1..1088 FT /note="Extended synaptotagmin-1" FT /id="PRO_0000234347" FT TOPO_DOM 1..30 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 31..51 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 52..54 FT /note="Lumenal" FT /evidence="ECO:0000255" FT TRANSMEM 55..75 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 76..1088 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 127..305 FT /note="SMP-LTD" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01194" FT DOMAIN 304..425 FT /note="C2 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00041" FT DOMAIN 446..572 FT /note="C2 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00041" FT DOMAIN 618..740 FT /note="C2 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00041" FT DOMAIN 771..888 FT /note="C2 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00041" FT DOMAIN 955..1077 FT /note="C2 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00041" FT REGION 1..38 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 599..630 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 911..930 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1002..1009 FT /note="Required for phosphatidylinositol 4,5-bisphosphate- FT dependent location at the cell membrane" FT /evidence="ECO:0000250" FT COMPBIAS 606..630 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 336 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000250" FT BINDING 337 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000250" FT BINDING 337 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000250" FT BINDING 349 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000250" FT BINDING 396 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000250" FT BINDING 396 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000250" FT BINDING 398 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000250" FT BINDING 398 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000250" FT BINDING 398 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000250" FT BINDING 400 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000250" FT BINDING 402 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000250" FT BINDING 403 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000250" FT MOD_RES 1 FT /note="N-acetylmethionine" FT /evidence="ECO:0000250|UniProtKB:Q9BSJ8" FT MOD_RES 316 FT /note="Phosphoserine; by CDK5" FT /evidence="ECO:0000250|UniProtKB:Q3U7R1" FT MOD_RES 806 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:Q9BSJ8" FT MOD_RES 809 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9BSJ8" FT MOD_RES 933 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9BSJ8" FT MOD_RES 947 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9BSJ8" FT MOD_RES 993 FT /note="Phosphotyrosine" FT /evidence="ECO:0007744|PubMed:22673903" FT CONFLICT 373 FT /note="H -> R (in Ref. 2; AAI01858)" FT /evidence="ECO:0000305" SQ SEQUENCE 1088 AA; 121159 MW; E7E12D9737FFB89D CRC64; MERSPEEGAG PEPSGQSPAT DSTRERDGGS GVPPAGPGAA SEALAVLTSF GRRLLVLVPV YLAGAAGLSV GFVLFGLALY LGWRRVRDGK ERSLRAARQL LDDEERITAE TLYMSHRELP AWVSFPDVEK AEWLNKIVVQ VWPFLGQYME KLLAETVAPA VRGANPHLQT FTFTRVELGE KPVRIIGVKV HPSQRKDQIL LDLNVSYVGD LQIDVEVKKY FCKAGVKGMQ LHGVLRVILE PLIGDLPIVG AVSMFFIKRP TLDINWTGMT NLLDIPGLSS LSDTMIMDSI AAFLVLPNRL LVPLVPDLQD VAQLRSPLPR GIIRIHLLAA RGLSSKDKYV KGLIEGKSDP YALVRVGTQT FCSRVIDEEL NPHWGETYEV IVHEVPGQEI EVEVFDKDPD KDDFLGRMKL DVGKVLQAGV LDNWYPLQGG QGQVHLRLEW LSLLPDAEKL DQVLQWNRGI TSRPEPPSAA ILVVYLDRAQ DLPLKKGNKE PNPMVQLSVQ DVTQESKATY STNCPVWEEA FRFFLQDPRS QELDVQVKDD SRALTLGALT LPLARLLTAS ELTLDQWFQL SSSGPNSRLY MKLVMRILYL DSSEMRLPTE PGAQDWDSES PETGSSVDAP PRPYHTTPNS HFGTENVLRI HVLEAQDLIA KDRFLGGLVK GKSDPYVKLK VAGRSLRTHV VREDLNPRWN EVFEVIVTSI PGQELDIEVF DKDLDKDDFL GRYKVGLTTV LNSGFLDEWL TLEDVPSGRL HLRLERLSPR PTAAELEEVL QVNSLIQTQK SSELAAALLS VYLERSEDLP LRKGTKPPSP YAILTVGETS HKTKTVSQTS APIWEESASF LIRKPHAESL ELQVRGEGTG TLGSISLPLS ELLQEEQLCL DRWFALSGQG QVLMRVQLGI LVSQHSGVEA HSHSSSSLNE EPEVLGDPTH TASPVLEVRH RLTHGDSPSE ALIGPLGQVK LTVWYHSDEQ KLISIIHSCR ALRQNGRDLP DPYVSVLLLP DKNRGTKRKT SQKKRTLNPE FNERFEWDLP LDGTLRRKLD VSVKSNSSFM SRERELLGKV QLDLAEIDLS QGAAQWYDLI DDRDKGGS //